ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial offers hope for Tough-to-Treat salivary gland cancers
Disease control OngoingThis study is testing whether combining two existing drugs—pemetrexed (chemotherapy) and pembrolizumab (immunotherapy)—can help control advanced salivary gland cancer. It is for adults whose cancer has returned or spread and is not curable with surgery or radiation. The main goal…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Experimental drug given before surgery shows promise against rare cancer
Disease control OngoingThis early-stage trial is testing whether giving the drug AL101 before standard surgery can help control adenoid cystic carcinoma, a rare type of cancer. The study involves 14 patients whose tumors have a specific genetic marker called NOTCH activation. Researchers will check if …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug duo targets Tough-to-Treat salivary gland cancers
Disease control OngoingThis study is testing whether two existing cancer drugs, lenvatinib and pembrolizumab, work together to treat advanced salivary gland cancers that have come back or spread. It will involve about 64 adults whose cancer has progressed and is no longer curable with standard treatmen…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC